ARTICLE | Clinical News
Gliovac regulatory update
January 27, 2014 8:00 AM UTC
The European Commission granted Orphan Drug designation to ERC Belgium's Gliovac to treat glioma. The vaccine consists of allogeneic and autologous haptenized and irradiated cells and cell lysates der...